ARCA biopharma Inc
ABIO
Market Cap$34.82M
Close$
$2.58
91.1% downside
Current Fair Value
91.1% downsideOvervalued by 91.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $34.82 Million |
|---|---|
| Enterprise Value | $1.53 Million |
| Dividend Yield | $3.18 (72.7291666666667%) |
| Earnings per Share | $-0.37 |
| Beta | 0.9 |
| Outstanding Shares | 14,506,879 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -58.03 |
|---|---|
| PEG | -32.32 |
| Price to Sales | - |
| Price to Book Ratio | 14.4 |
| Enterprise Value to Revenue | 8.72 |
| Enterprise Value to EBIT | -0.17 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ARCA biopharma Inc
CEO: Michael Bristow